Prescribing for diabetes in England : 2004/05 to 2009/10
This report is the latest in a series of publications on diabetes by the (NHS Information Centre)
‘Needless’ diabetes tests may be cut to save £2.5m
The move has been praised, with politicians saying this is exactly the kind of efficiency saving needed to cope with demanding budget cuts that will be faced by NHS Lothian (Edinburgh Evening News)
Health Care Transition in Adolescents and Young Adults With Diabetes
Health care providers can take a leading role in the health care transition of adolescents and young adults with diabetes (Clinical Diabetes)
Incidence of Type 1 diabetes in Australian children 2000-2008
Incidence of Type 1 diabetes in Australian children 2000-2008 presents the latest available national data on new cases of Type 1 diabetes for children from Australia’s National Diabetes Register (Australian Government)
Dietary interventions and physical activity interventions for weight management before, during and after pregnancy
The guidance includes six recommendations which are based on approaches that have been proven to be effective for the whole population (NICE)
Screening for Diabetes and Prediabetes With Proposed A1c-Based Diagnostic Criteria
The proposed A1c diagnostic criteria are insensitive and racially discrepant for screening, missing most undiagnosed Americans with diabetes and prediabetes (Diabetes Care)
The impact of diabetes education on blood glucose self-monitoring among older adults
This study suggests that diabetes education is associated with self-management behaviour in real-world clinical care. These findings support the effectiveness of self-management education programmes to increase self-care behaviours (Journal of Evaluation in Clinical Practice)
Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus
In this study, we have harnessed the inherent property of insulin to aggregate into an oligomeric intermediate on the pathway to amyloid formation, to generate a form that exhibits controlled and sustained release for extended periods. Supporting information (PNAS)
Finesse Insulin Patch-Pen for Three-Day Use With Novolog
Calibra Medical announced that it received 510(k) clearance from the U.S. Food and Drug Administration to market its Finesse insulin patch-pen for up to three-day use with Novo Nordisk’s Novolog® rapid acting insulin (PharmaLive)
Novo earnings leap as Victoza take-up impresses
Novo Nordisk has posted a healthy set of figures for the first half this morning, helped by a good start for its new diabetes drug Victoza (PharmaTimes)
Glycosmedia is also available as an App: